Security Snapshot

Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) Institutional Ownership

CUSIP: 071734107

13F Institutional Holders and Ownership History from Q2 2015 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

171

Shares (Excl. Options)

189.5MFull value: 189,502,796 · shares · 30 Sep 2026

Price

$5.83

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-2,518,292
Value change
+$544,919
Number of holders
171
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
374,002,024
SEC-reported price per share
$8.91
Insider filing price
$8.91
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BHC - Bausch Health Companies Inc. - Common Shares, No Par Value is tracked under CUSIP 071734107.
  • 171 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 216 to 171 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.18BFull value: $1,178,972,762 · USD · 30 Jun 2026
    to
    $1.11BFull value: $1,112,902,516 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 171 institutions filings for Q3 2026.

Open SEC evidence

Security key

071734107

13F reference period

Q3 2026

13F holders

171

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
BHC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PAULSON & CO. INC. 19% +113% $468,403,853 +$251,322,786 70,755,869 +116% PAULSON & CO. INC. 14 Aug 2025
MERUELO ALEX 10% $198,881,273 36,761,788 Alex Meruelo 31 Mar 2025
GOLDENTREE ASSET MANAGEMENT LP 9.5% $233,313,373 35,243,712 Steven A. Tananbaum 30 Jun 2025
NOMURA HOLDINGS INC 4.2% -35% $101,317,148 -$49,580,602 15,708,085 -33% NOMURA HOLDINGS INC 30 Sep 2025
As of 30 Sep 2026, 171 institutional investors reported holding
189.5MFull value: 189,502,796 · shares · 30 Sep 2026
shares of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC). This represents 51% of the company’s total
374MFull value: 374,002,024 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
45%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PAULSON & CO. INC. 20% 73,255,869 15% $427,081,716
GOLDENTREE ASSET MANAGEMENT LP 9.3% 34,665,731 11% $201,870,027
GOLDMAN SACHS GROUP INC 2.1% 7,748,378 0.01% $45,173,043
VANGUARD CAPITAL MANAGEMENT LLC 2% 7,444,589 0% $43,364,731
TWO SIGMA INVESTMENTS, LP 2% 7,410,215 0.03% $43,201,553
MFN Partners Management, LP 1.6% 6,000,000 0.73% $34,980,000
Point72 Asset Management, L.P. 0.89% 3,312,674 0.03% $19,312,589
GEODE CAPITAL MANAGEMENT, LLC 0.88% 3,296,234 0% $26,841,048
DIMENSIONAL FUND ADVISORS LP 0.81% 3,033,209 0% $17,682,464
MARSHALL WACE, LLP 0.69% 2,570,980 0.01% $14,997,109
VANGUARD FIDUCIARY TRUST CO 0.61% 2,295,106 0% $13,368,992
RENAISSANCE TECHNOLOGIES LLC 0.55% 2,055,272 0.02% $11,982,236
Hillsdale Investment Management Inc. 0.53% 1,997,343 0.26% $11,635,950
PRIVATE MANAGEMENT GROUP INC 0.45% 1,672,757 0.27% $9,752,173
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.43% 1,607,371 0.01% $9,373,154
Trexquant Investment LP 0.33% 1,250,823 0.05% $7,292,298
MACKENZIE FINANCIAL CORP 0.31% 1,173,969 0.01% $6,836,813
BANK OF AMERICA CORP /DE/ 0.31% 1,146,154 0% $6,682,078
TD ASSET MANAGEMENT INC 0.25% 946,284 0% $5,466,959
Bridgewater Associates, LP 0.25% 942,585 0.02% $5,495,271
Vanguard Global Advisers, LLC 0.24% 899,317 0% $5,238,522
Qube Research & Technologies Ltd 0.22% 837,389 0% $4,881,978
Chicago Partners Investment Group LLC 0.2% 757,203 0.09% $4,876,387
GAMCO INVESTORS, INC. ET AL 0.18% 691,656 0.04% $4,032,354
CIBC WORLD MARKET INC. 0.17% 641,095 0.01% $3,735,365

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
38
Headline period
Q3 2026
Rows shown
1-25 of 38
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 189,502,796 $1,112,902,516 +$544,919 $5.83 171
2026 Q2 237,133,071 $1,178,972,762 +$22,560,864 $4.93 216
2026 Q1 232,755,548 $1,265,014,647 -$26,078,118 $5.40 226
2025 Q4 235,846,050 $1,642,616,856 -$18,971,160 $6.95 234
2025 Q3 240,512,549 $1,554,040,468 -$31,704,230 $6.45 217
2025 Q2 245,981,587 $1,639,621,154 +$16,931,558 $6.66 207
2025 Q1 243,557,406 $1,578,216,314 -$74,545,200 $6.47 224
2024 Q4 245,891,962 $1,982,171,691 -$21,304,486 $8.06 218
2024 Q3 254,967,055 $2,082,407,513 -$179,326,429 $8.16 205
2024 Q2 279,601,698 $1,950,569,289 -$48,798,291 $6.97 224
2024 Q1 267,121,300 $2,833,903,009 -$6,695,968 $10.61 222
2023 Q4 285,551,727 $2,286,717,170 +$23,837,817 $8.02 227
2023 Q3 282,390,339 $2,325,551,670 +$141,348,856 $8.22 217
2023 Q2 265,165,149 $2,119,508,040 -$46,064,459 $8.00 226
2023 Q1 277,673,375 $2,249,589,375 -$139,394,547 $8.10 230
2022 Q4 279,994,103 $1,758,059,426 +$233,519,373 $6.28 246
2022 Q3 242,453,235 $1,673,203,434 -$25,067,694 $6.89 258
2022 Q2 240,967,724 $2,017,735,972 -$557,656,647 $8.36 294
2022 Q1 255,743,085 $5,849,543,401 -$157,537,424 $22.85 351
2021 Q4 259,865,326 $7,175,732,003 +$49,440,794 $27.61 359
2021 Q3 253,309,230 $7,068,384,962 +$43,440,961 $27.85 327
2021 Q2 252,392,175 $7,398,066,380 +$246,877,089 $29.32 343
2021 Q1 238,183,989 $7,551,331,532 +$509,827,369 $31.74 333
2020 Q4 231,045,000 $4,816,727,618 +$197,335,196 $20.80 315
2020 Q3 223,601,137 $3,484,209,772 -$62,682,863 $15.54 303
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .